| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Day One Biopharmaceuticals, Inc. (DAWN) has 13 insiders with recent SEC Form 4 filings, including 0 buys and 10 sells. DAWN is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 355.0K | $7.64M | - | |
| CFO | 188.0K | $4.05M | - | |
| Other | 171.0K | $3.68M | - | |
| Other | 105.0K | $2.26M | - | |
| Other | 74.0K | $1.59M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 16, 2025 | York Charles N II76 | COO, CFO And Secretary | Sale+OE | 4,282 | $6.26 | $26,796.33 | -1.6% | 0.0% | - | |
| May 16, 2025 | Bender Jeremy76 | Chief Executive Officer | Sale+OE | 13,964 | $6.26 | $87,385.32 | -8.7% | 0.0% | - | |
| Feb 18, 2025 | York Charles N II76 | COO, CFO And Secretary | Sale+OE | 4,370 | $11.96 | $52,278.31 | -1.7% | -45.7% | -3.1% | |
| Feb 18, 2025 | Dubow Adam63 | General Counsel | Sale+OE | 4,646 | $11.96 | $55,580.10 | -10.5% | -45.7% | -3.1% | |
| Feb 18, 2025 | Bender Jeremy76 | Chief Executive Officer | Sale+OE | 12,048 | $11.96 | $144,130.22 | -8.6% | -45.7% | -3.1% | |
| Dec 10, 2024 | Blackman Samuel C.77 | Head Of R&D | Sell | 30,000 | $13.31 | $399,339.00 | -2.8% | -39.0% | -35.6% | |
| Nov 18, 2024 | Bender Jeremy76 | Chief Executive Officer | Sale+OE | 10,554 | $13.21 | $139,420.45 | -8.9% | -8.3% | -34.1% | |
| Nov 18, 2024 | Blackman Samuel C.77 | Head Of R&D | Sale+OE | 2,206 | $13.21 | $29,141.70 | -0.2% | -8.3% | -34.1% | |
| Nov 18, 2024 | Dubow Adam63 | General Counsel | Sale+OE | 3,165 | $13.21 | $41,810.28 | -9.0% | -8.3% | -34.1% | |
| Nov 18, 2024 | York Charles N II76 | COO, CFO And Secretary | Sale+OE | 2,602 | $13.21 | $34,372.94 | -1.1% | -8.3% | -34.1% |